Physician profile
Alpash Patel
NPI 1598731374
$26,070.00
in general payments reported to CMS, 2019-2025
22 companies · $3,899 in 2025
The $3,899 reported for 2025 was more than what 91% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $875 · 2020: $933 · 2021: $1,031 · 2022: $9,526 · 2023: $8,989 · 2024: $818 · 2025: $3,899.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,268 · Food and Beverage: $3,360 · Travel and Lodging: $1,930 · Long Term Medical Supply Or Device Loan: $147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,268.33 |
| Food and Beverage | $3,360.31 |
| Travel and Lodging | $1,930.39 |
| Long Term Medical Supply Or Device Loan | $146.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aroa Biosurgery Incorporated | $17,676.38 | 2022-2025 | |
| Smith+Nephew, INC. | $3,260.81 | 2019-2025 | Collagenase Santyl, Pico, Versajet |
| Kerecis Limited | $1,672.04 | 2019-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Mimedx Group, INC. | $1,411.54 | 2024-2025 | |
| Horizon Therapeutics Plc | $449.36 | 2022-2023 | Krystexxa |
| Celularity INC. | $385.00 | 2019 | |
| Paratek Pharmaceuticals, INC. | $296.75 | 2021-2025 | Nuzyra |
| Integra Lifesciences Corporation | $186.09 | 2021-2024 | Acell |
| Convatec INC. | $177.17 | 2023-2025 | |
| Cook Medical LLC | $160.71 | 2023 | Zilver Vena |
| Next Science LLC | $117.60 | 2025 | Xperience, Blastx |
| Amgen INC. | $50.52 | 2024-2025 | Krystexxa |
| Hartmann USA, INC. | $48.80 | 2021-2023 | Zetuvit Plus |
| Urgo Medical North America, LLC | $29.38 | 2025 | Urgoclean Ag |
| Organogenesis INC. | $24.06 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $23.66 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Kci USA, INC. | $22.34 | 2019 | |
| Acera Surgical, INC. | $17.75 | 2024 | Restrata Wound Matrix |
| Abbvie INC. | $16.52 | 2025 | |
| Melinta Therapeutics, LLC | $15.54 | 2020 | |
| Coloplast Corp | $14.61 | 2025 | |
| Medela LLC | $13.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alpash Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.